Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma (2009)
Neyns, B., Sadones, J., Joosens, E., Bouttens, F., Verbeke, L., ...
Background: To evaluate the antitumor activity and toxicity of single-agent cetuximab in patients with recurrent high-grade glioma (HGG) after failure of surgery, radiation therapy, and chemotherapy....
Michotte, A, Godfraind, C, Quoilin, S, ...
From 1998 a prospective surveillance study of Creutzfeldt-Jakob disease (CJD) has been initiated in Belgium. In addition to epidemiological data, information on cerebrospinal fluid biomarkers, prion...